13-36295837-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144981.3(CCDC169):āc.104T>Cā(p.Ile35Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000454 in 1,540,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001144981.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC169 | NM_001144981.3 | c.104T>C | p.Ile35Thr | missense_variant | 2/8 | ENST00000239859.8 | NP_001138453.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC169 | ENST00000239859.8 | c.104T>C | p.Ile35Thr | missense_variant | 2/8 | 5 | NM_001144981.3 | ENSP00000239859.7 | ||
CCDC169-SOHLH2 | ENST00000511166.1 | c.-97+1800T>C | intron_variant | 2 | ENSP00000421868.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000645 AC: 1AN: 154946Hom.: 0 AF XY: 0.0000122 AC XY: 1AN XY: 81864
GnomAD4 exome AF: 0.00000216 AC: 3AN: 1388404Hom.: 0 Cov.: 26 AF XY: 0.00000438 AC XY: 3AN XY: 685084
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2024 | The c.104T>C (p.I35T) alteration is located in exon 2 (coding exon 2) of the CCDC169 gene. This alteration results from a T to C substitution at nucleotide position 104, causing the isoleucine (I) at amino acid position 35 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at